All articles by Andrew Turley – Page 5
-
Business
Solvay rare earth recycling in France
€15 million investment in two new sites to diversify supply
-
Business
Regorafenib approved in US
Stivarga tablets approved for treatment of advanced colorectal cancer
-
Business
Sanofi to cut 900 jobs in France
Number of jobs to be cut reduced from 2500 to 900 following outcry
-
BusinessMeasuring nano the European way
Report concludes that companies will need lots of methods to define nanomaterials
-
Business
Pineapple gel approved for burns
EU regulators approve NexoBrid gel from MediWound for removal of scab tissue
-
Business
Bayer $145 million animal health deal
Move will strengthen anti-infective portfolio and introduce reproductive hormones
-
Business
Drug discovery becomes Facebook game
Boehringer Ingelheim offers a first look at the beta version of Syrum
-
Business
Solvay adds fluorinated capacity
Company will double capacity at plant in Salindres, France, which makes triflic acid
-
BusinessBASF backs automotive growth
While other chemical companies are trying to reduce their exposure to the automotive industry, BASF is heading in the other direction
-
Business
Merck KGaA to cut 1100 German jobs
Company provides detail of restructuring programme announced in February
-
Business
DuPont sells car paints for $5bn
US investment group picks up 11,000 employees and $4 billion in annual sales
-
Business
Kevlar equivalent banned for 20 years
US rules in favour of DuPont in Kevlar trade secrets case
-
BusinessCrowdsourcing science site to launch
Marblar aims to find uses for neglected patents by ‘gamifying’ the technology transfer process
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
-
Business
Rockwood to pay C$720m for lithium firm
The chemical group has struck a deal to buy Talison, an Australian lithium producer with headquarters in Perth.